March 2024 - Page 234 of 237

NASDAQ Companies - March 1, 2024

BioVie’s NE3107 Demonstrates Potential Improvements in Motor and Non-motor Symptoms for Parkinson’s Disease Patients and May Be Realigning Physiological Processes for Alzheimer’s Patients in Data to be Presented at the International Conference on Alzheimer’s and Parkinson’s Diseases 2024

Data from Phase 2a trial in Parkinson’s Disease suggest patients treated with NE3107 experienced significant improvements in non-motor symptoms and […]

NASDAQ Companies - March 1, 2024

Karat Packaging to Report 2023 Fourth Quarter and Full Year Financial Results and Host Conference Call on Thursday, March 14, 2024

CHINO, Calif., March 01, 2024 (GLOBE NEWSWIRE) — Karat Packaging Inc. (“Karat” or the “Company”) (Nasdaq: KRT), a specialty distributor […]

TSX News - March 1, 2024

Euro Sun Mining Concludes Successful Meetings with Romanian Ministries and Issues Promissory Note

TORONTO, March 01, 2024 (GLOBE NEWSWIRE) — Euro Sun Mining Inc., (TSX: ESM) (“Euro Sun” or the “Company”) is pleased […]

Canadian Stock Exchange News - March 1, 2024

Refined Metals Corp. Announces Planned Name Change to Refined Energy Corp.

VANCOUVER, British Columbia, March 01, 2024 (GLOBE NEWSWIRE) — Refined Metals Corp. (CSE: RMC; OTC: RFMCF; FRA: CWA0) (the “Company”) […]

NASDAQ Companies - March 1, 2024

PainReform Provides Year-End Business Update

Reports continued enrollment in the second part of the Phase 3 clinical trial in bunionectomy Remains on track to announce […]

NASDAQ Companies - March 1, 2024

Prime Medicine Reports Full Year 2023 Financial Results and Provides Business Updates

— Maturing into clinical-stage company; on-track to file IND application or CTA for PM359 in 1H 2024, with initial data […]

NASDAQ Companies - March 1, 2024

Praxis Precision Medicines to Participate in TD Cowen’s 44th Annual Health Care Conference

BOSTON, March 01, 2024 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights […]

NASDAQ Companies - March 1, 2024

Recursion to Participate in Upcoming Investor Conferences

SALT LAKE CITY, March 01, 2024 (GLOBE NEWSWIRE) — Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology […]

NASDAQ Companies - March 1, 2024

Atlantica Reports 2023 Financial Results

Atlantica Reports 2023 Financial Results Net profit for 2023 attributable to the Company was $43.4 million, compared with a net […]

NASDAQ Companies - March 1, 2024

Shenandoah Telecommunications Company to Sell its Towers for $310 Million

EDINBURG, Va., March 01, 2024 (GLOBE NEWSWIRE) — Shenandoah Telecommunications Company (“Shentel” or the “Company”) (Nasdaq: SHEN) announced that it […]